Tag:
OMS103HP
Latest Headlines
Latest Headlines
Omeros shares spike on positive Phase II pain data
Shares of Omeros jumped 28 percent this morning after the developer announced that its lead experimental drug produced positive data in a Phase II study. Omeros said that patients treated with
